Literature DB >> 34012632

The clinical potential of circulating immune cell counts in primary gastric lymphoma.

Ayman Haimour1, Osama Abu-Shawer2, Mohammad Abu-Shawer3, Ali Al-Taji4, Tamer Altamimi5, Razan Mansour6, Justin Z Amarin6, Hala Sultan4, Maysa Al-Hussaini7.   

Abstract

BACKGROUND: High neutrophil-lymphocyte ratio (NLR) is linked to poor overall survival (OS) in gastrointestinal tract cancers. This study explores the clinical value of NLR, in addition to absolute lymphocyte count (ALC) and other hematologic parameters in association with distant metastases and OS in primary gastric lymphoma (PGL) patients.
METHODS: Clinical data of 139 PGL patients who received treatment at King Hussein Cancer Center (KHCC), Amman-Jordan were retrospectively evaluated. Using data from complete blood count (CBC) tests, the following hematologic parameters: absolute neutrophil count (ANC), ALC, absolute eosinophil count (AEC), absolute monocyte count (AMC), NLR, platelet-lymphocyte ratio (PLR), and monocyte-lymphocyte ratio (MLR) were assessed in association with the following clinical outcomes: presence or absence of baseline distant metastases and OS. We conducted univariate and multivariate analyses assessing the various hematologic parameters in association with distant metastases.
RESULTS: Univariate and multivariate analyses indicated that patients with an elevated NLR (>3.14) displayed more baseline distant metastases compared to patients with a low NLR (≤3.14), (P value: 0.02 and 0.018, respectively). High baseline ALC (>1,819/µL) was associated with lower baseline distant metastases (P value: 0.04). In the OS analysis, high baseline ANC (>5,100/µL), NLR (>2.75), and PLR (>0.16) were associated with poor OS, (P value: 0.027, 0.016, and 0.011 respectively).
CONCLUSIONS: High NLR and ALC were associated with baseline distant metastases. High baseline ANC, NLR, and PLR were associated with poor OS. Hematologic parameters might be potentially helpful in assessing and correlating NLR with the response success to treatment in PGL. 2021 Journal of Gastrointestinal Oncology. All rights reserved.

Entities:  

Keywords:  Primary gastric lymphoma (PGL); distant metastases; neutrophil-lymphocyte ratio (NLR)

Year:  2021        PMID: 34012632      PMCID: PMC8107611          DOI: 10.21037/jgo-20-383

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  48 in total

Review 1.  Extranodal lymphomas.

Authors:  E Zucca; F Cavalli
Journal:  Ann Oncol       Date:  2000       Impact factor: 32.976

2.  Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis.

Authors:  Dominic E Sanford; Brian A Belt; Roheena Z Panni; Allese Mayer; Anjali D Deshpande; Danielle Carpenter; Jonathan B Mitchem; Stacey M Plambeck-Suess; Lori A Worley; Brian D Goetz; Andrea Wang-Gillam; Timothy J Eberlein; David G Denardo; Simon Peter Goedegebuure; David C Linehan
Journal:  Clin Cancer Res       Date:  2013-05-07       Impact factor: 12.531

Review 3.  Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas.

Authors:  E Zucca; E Roggero; F Bertoni; F Cavalli
Journal:  Ann Oncol       Date:  1997-08       Impact factor: 32.976

4.  HLA-DQA1*0103-DQB1*0601 haplotype and Helicobacter pylori-positive gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  Yoshiro Kawahara; Motowo Mizuno; Tadashi Yoshino; Kenji Yokota; Keiji Oguma; Hiroyuki Okada; Shigeatsu Fujiki; Yasushi Shiratori
Journal:  Clin Gastroenterol Hepatol       Date:  2005-09       Impact factor: 11.382

5.  Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma.

Authors:  Fabio Munari; Silvia Lonardi; Marco A Cassatella; Claudio Doglioni; Maria Giulia Cangi; Amedeo Amedei; Fabio Facchetti; Yoshinobu Eishi; Massimo Rugge; Matteo Fassan; Marina de Bernard; Mario M D'Elios; William Vermi
Journal:  Blood       Date:  2011-04-28       Impact factor: 22.113

Review 6.  Eradication therapy in Helicobacter pylori-negative, gastric low-grade mucosa-associated lymphoid tissue lymphoma patients: a systematic review.

Authors:  Angelo Zullo; Cesare Hassan; Lorenzo Ridola; Vincenzo De Francesco; Luigi Rossi; Silverio Tomao; Dino Vaira; Robert M Genta
Journal:  J Clin Gastroenterol       Date:  2013 Nov-Dec       Impact factor: 3.062

7.  CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers.

Authors:  Osamu Wakabayashi; Koichi Yamazaki; Satoshi Oizumi; Fumihiro Hommura; Ichiro Kinoshita; Shigeaki Ogura; Hirotoshi Dosaka-Akita; Masaharu Nishimura
Journal:  Cancer Sci       Date:  2003-11       Impact factor: 6.716

Review 8.  Immune cell promotion of metastasis.

Authors:  Takanori Kitamura; Bin-Zhi Qian; Jeffrey W Pollard
Journal:  Nat Rev Immunol       Date:  2015-02       Impact factor: 53.106

9.  The clinical value of peripheral immune cell counts in pancreatic cancer.

Authors:  Osama Abu-Shawer; Mohammad Abu-Shawer; Abdullah Shurman; Ali Lattouf; Ayman Haimour; Omar Hamdan; Razan Mansour; Tamer Altamimi; Maysa Al-Hussaini
Journal:  PLoS One       Date:  2020-06-15       Impact factor: 3.240

10.  Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patients.

Authors:  Monica Khunger; Pradnya Dinkar Patil; Arjun Khunger; Manshi Li; Bo Hu; Sagar Rakshit; Arnab Basu; Nathan Pennell; James P Stevenson; Paul Elson; Tanmay S Panchabhai; Vamsidhar Velcheti
Journal:  PLoS One       Date:  2018-10-25       Impact factor: 3.240

View more
  1 in total

1.  The Predictive Value of Peripheral Immune Cell Counts for the Presence of Brain Metastases in Stage IV Non-Small-Cell Lung Cancer (NSCLC).

Authors:  I Abuelbeh; O Abu-Shawer; M Abu-Shawer; M Alkderat; M Safi; A Alwazani; A Alkhatib; B Abu-Hussain; M Aladawi; S Ismail; T Altamimi; Taher Abu Hejleh
Journal:  Avicenna J Med       Date:  2022-07-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.